Trade

with

Foundation Medicine Inc
(NASDAQ: FMI)
AdChoices
24.71
+1.71
+7.43%
After Hours :
24.71
0.00
0.00%

Open

22.36

Previous Close

23.00

Volume (Avg)

250.01k (241.54k)

Day's Range

22.36-24.84

52Wk Range

18.25-45.00

Market Cap.

698.32M

Dividend Rate ( Yield )

-

Beta

-

Shares Outstanding

28.26M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 28.99M

    • Net Income

    • -42.94M

    • Market Cap.

    • 698.32M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -117.63

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -

    • Forward P/E

    • -20.75

    • Price/Sales

    • 12.25

    • Price/Book Value

    • 6.47

    • Price/Cash flow

    • -11.89

      • EBITDA

      • -36.76M

      • Return on Capital %

      • -56.36

      • Return on Equity %

      • -69.59

      • Return on Assets %

      • -56.36

      • Book Value/Share

      • 3.82

      • Shares Outstanding

      • 28.26M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 42.00

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -1.42

        • Cashflow Estimate

        • -1.44

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 144.90

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -

          • -5.55

          • Net Income

            Q/Q (last year)

          • -

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 47.82

          • Net Income

            5-Year Annual Average

          • -

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 56.71

            • 42.70

            • Pre-Tax Margin

            • -117.52

            • 11.63

            • Net Profit Margin

            • -117.63

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 8.43

              • 1.23

              • Quick Ratio

              • 8.13

              • 0.76

              • Interest Coverage

              • -

              • 5.98

              • Leverage Ratio

              • 1.21

              • 2.16

              • Book Value/Share

              • 3.82

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -9.39

                • 33.22

                • P/E Ratio 5-Year High

                • -18.96

                • 325.07

                • P/E Ratio 5-Year Low

                • -7.69

                • 154.73

                • Price/Sales Ratio

                • 11.05

                • 2.34

                • Price/Book Value

                • 5.83

                • 3.04

                • Price/Cash Flow Ratio

                • -11.89

                • 19.08

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -69.59

                    (-)

                  • 9.34

                    (9.80)

                  • Return on Assets %

                    (5-Year Average)

                  • -56.36

                    (-)

                  • 4.63

                    (5.44)

                  • Return on Capital %

                    (5-Year Average)

                  • -68.53

                    (-)

                  • 5.73

                    (6.77)

                  • Income/Employee

                  • -

                  • 17.17k

                  • Inventory Turnover

                  • 11.44

                  • 5.07

                  • Asset Turnover

                  • 0.48

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -41.76M
                  Operating Margin
                  -144.05
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -11.89
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  99.91%

                  Mutual Fund Ownership

                  21.90%

                  Float

                  58.23%

                  5% / Insider Ownership

                  3.99%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity® OTC Portfolio

                  •  

                    1,593,212

                  • 0.00

                  • 5.64

                  • Fidelity® Select Biotechnology Portfolio

                  •  

                    901,500

                  • 0.00

                  • 3.19

                  • Lord Abbett Developing Growth Fund

                  •  

                    721,812

                  • 35.26

                  • 2.58

                  • Vanguard Total Stock Mkt Idx

                  •  

                    385,119

                  • 80.50

                  • 1.36

                  • iShares Russell 2000 (AU)

                  •  

                    210,653

                  • -1.46

                  • 0.90

                  • Fidelity Advisor® Biotechnology Fund

                  •  

                    159,200

                  • 0.00

                  • 0.56

                  • Pacific Select Fund Small-Cap Growth

                  •  

                    148,072

                  • 12.02

                  • 0.53

                  • Vanguard Extended Market Index Fund

                  •  

                    119,340

                  • 105.04

                  • 0.42

                  • Alger Small Cap Growth Institutional Fd

                  •  

                    116,600

                  • 7.07

                  • 0.42

                  • Wells Fargo Advantage Emerging Gr Fund

                  •  

                    112,058

                  • -0.13

                  • 0.40

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Third Rock Ventures, LLC

                  •  

                    4,927,234

                  • 0.00%

                  • 17.43

                  • Wellington Management Company, LLP

                  •  

                    2,148,923

                  • +49.27%

                  • 7.68

                  • Lord, Abbett & Co LLC

                  •  

                    1,192,937

                  • +46.34%

                  • 4.26

                  • Vanguard Group, Inc.

                  •  

                    330,782

                  • +77.09%

                  • 1.18

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Diagnostics & Research

                  Type

                  Distressed

                  Style

                  -

                  Foundation Medicine Inc is a commercial-stage company. The Company is engaged in changing the way patients with cancer are treated. It delivers genomic information about cancer to its customers.

                  Key People

                  Dr. Michael J. Pellini,M.D.

                  CEO/Director/President

                  Alexis Borisy,A.M.

                  Chairman of the Board/Director

                  Brook H. Byers

                  Director

                  Evan Jones

                  Director

                  David P. Schenkein

                  Director

                  • Foundation Medicine Inc

                  • 150 Second Street

                  • Cambridge, MA 02141

                  • USA.Map

                  • Phone: +1 617 418-2200

                  • Fax: +1 617 418-2201

                  • foundationmedicine.com

                  Incorporated

                  2009

                  Employees

                  372

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: